Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Transcode TherapeuticsRNAZ | Open-market buy | 23/09/28 | 23/10/02 | 98,000 sh | $0.51 | $49,980 | +119.1% | |
Transcode TherapeuticsRNAZ | Open-market buy | 23/09/28 | 23/10/02 | 49,350 sh | $0.51 | $25,168.5 | +708.2% | |
Transcode TherapeuticsRNAZ | Open-market buy | 23/06/20–23/06/21 | 23/06/22 | 18,607 sh2 trades | $2.61avg. | $48,647.85 | +29.2% | |
Transcode TherapeuticsRNAZ | Open-market buyAmendment | 23/06/09 | 23/06/14 | 19,000 sh | $2.76 | $52,440 | +45.1% | |
Transcode TherapeuticsRNAZ | Open-market buy | 23/06/09 | 23/06/13 | 19,000 sh | $2.76 | $52,440 | +2.1% |